The MiDAS ENCORE Study

计划入组 302 人 · 首次发布于 2014 年 3 月 21 日

Management Of Asthi Dhatu Kshaya Vikara (Osteoporosis)

计划入组 40 人

Observational Study on Manasa Prakruti and Mental Wellbeing

计划入组 300 人

Rasagiline transdermal patch(Teikoku Seiyaku Co. Ltd.)

Tilactase

Kallidinogenase

Rx

MIKASA SEIYAKU CO., LTD.

Japan

Tanabe Seiyaku Co Ltd

United States

TEIKOKU SEIYAKU CO.,LTD.

Japan

AFT Pharmaceuticals Licenses Non-Opioid Maxigesic IV to Mikasa Seiyaku for Japan

AGC Biologics Partners with Teikoku Seiyaku for Novel rhMMP-7 Therapy Manufacturing to Treat Lumbar Disc Herniation

Energenesis Biomedical and Taiwan Tanabe Seiyaku Enter Joint Development Agreement for Diabetic Foot Ulcer Candidate ENERGI-F703DFU